CDT Equity Inc. Total Assets
CDT Equity Inc. total assets. Based on the latest financial reports, CDT Equity Inc. (CDT) holds total assets worth $3.50 Billion USD as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see CDT Equity Inc. (CDT) market capitalisation for the company's overall valuation and market capitalisation.
Total Assets of CDT Equity Inc. (2021–2025)
Total assets of CDT Equity Inc. from 2021 to 2025. This chart illustrates how CDT Equity Inc.'s total assets have evolved over time, based on quarterly financial data. See CDT Equity Inc. stock quote for real-time trading data and today's change.
CDT Equity Inc. - Asset Composition Analysis
CDT Equity Inc. Total Assets Breakdown (December 2025)
CDT Equity Inc. total assets breakdown as of December 2025. CDT Equity Inc.'s total assets of $3.50 Billion consist of 38.1% current assets and 61.9% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 11.0% |
| Accounts Receivable | $462.85 Million | 13.1% |
| Inventory | $402.35 Million | 11.4% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $399.80 Million | 11.3% |
| Goodwill | $1.04 Billion | 29.3% |
Asset Composition Trend (2021–2025)
This chart illustrates how CDT Equity Inc.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore CDT Equity Inc. current assets vs equity to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: CDT Equity Inc.'s current assets represent 38.1% of total assets in 2025, a decrease from 48.9% in 2021.
- Cash Position: Cash and equivalents constituted 11.0% of total assets in 2025, down from 22.8% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 40.0% of total assets, an increase from 0.0% in 2021.
- Asset Diversification: The largest asset category is goodwill at 29.3% of total assets.
CDT Equity Inc. Competitors by Total Assets
Key competitors of CDT Equity Inc. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
USA | $11.57 Billion |
|
Madrigal Pharmaceuticals Inc
NASDAQ:MDGL
|
USA | $1.26 Billion |
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SHG:603392
|
China | CN¥13.56 Billion |
|
Metsera, Inc. Common Stock
NASDAQ:MTSR
|
USA | $639.66 Million |
|
Xiamen Amoytop Biotech Co Ltd
SHG:688278
|
China | CN¥3.21 Billion |
|
SOLENO THERAPEUT. DL-001
F:6XC
|
Germany | €563.83 Million |
|
89bio Inc
NASDAQ:ETNB
|
USA | $603.49 Million |
|
LegoChem Biosciences Inc
KQ:141080
|
Korea | ₩652.93 Billion |
CDT Equity Inc. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.14 | 1.45 | 0.54 |
| Quick Ratio | 1.49 | -86.65 | 0.54 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $741.05 Million | $1.97 Million | $-88.34K |
CDT Equity Inc. - Advanced Valuation Insights
This section examines the relationship between CDT Equity Inc.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.01 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 84412.8% |
| Total Assets | $3.54 Billion |
| Market Capitalization | $407.55K USD |
Valuation Analysis
Below Book Valuation: The market values CDT Equity Inc.'s assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: CDT Equity Inc.'s assets grew by 84412.8% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for CDT Equity Inc. (2021–2025)
The table below shows the annual total assets of CDT Equity Inc. from 2021 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $3.54 Billion | +84412.78% |
| 2024-12-31 | $4.19 Million | -41.96% |
| 2023-12-31 | $7.22 Million | +144380.00% |
| 2022-12-31 | $5.00K | -97.65% |
| 2021-12-31 | $213.12K | -- |
About CDT Equity Inc.
CDT Equity Inc., a data-driven biopharmaceutical company, focuses on identifying, enhancing, and monetising therapeutic assets. The company's pipeline includes AZD1656, a glucokinase activator that is in Phase II trials for the treatment of autoimmune disorders, including uveitis, Hashimoto's thyroiditis, preterm labor, and renal transplant; AZD5658, which is in Phase I clinical trial for the tre… Read more